Albert S K Chan

Title: Albert S K Chan: Innovator in Radioprotectant Peptides

Introduction

Albert S K Chan is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of radioprotectants, particularly in the development of methods to enhance the stability of radiolabeled peptides. His innovative work has implications for various applications, especially in the medical and pharmaceutical industries.

Latest Patents

One of Albert S K Chan's key patents is titled "Radioprotectant for peptides labeled with radioisotope." This patent describes a method for ameliorating the degradation of radiolabeled peptides, including radiolabeled proteins such as antibodies. The invention involves the inclusion of povidone, also known as polyvinylpyrrolidone or PVP, as a radioprotectant in a composition containing a radiolabeled peptide. Additionally, the patent outlines a radioprotectant composition and a stable peptide-radioisotope composition that incorporates povidone. To further enhance radioprotection, ascorbic acid or other secondary stabilizers may also be added to the compositions.

Career Highlights

Albert S K Chan is currently associated with Coulter Pharmaceutical, Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential to improve the efficacy and safety of radiolabeled therapies.

Collaborations

Throughout his career, Albert has collaborated with esteemed colleagues, including David Colcher and Dan Shochat. These partnerships have contributed to the advancement of his research and the successful development of innovative solutions in the field.

Conclusion

Albert S K Chan is a distinguished inventor whose work in radioprotectant peptides has the potential to significantly impact the pharmaceutical industry. His innovative approaches to enhancing the stability of radiolabeled compounds demonstrate his commitment to advancing medical science.